LAB. CORP.OF AMER. DL-,10
LAB. CORP.OF AMER. DL-,10/ US50540R4092 /
LAB
22/05/2024 18:14:28
|
Var.
-
|
Volume |
Denaro- |
Lettera- |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
188.00EUR
|
-
|
- Fatturato: - |
-Quantità in denaro: - |
-Quantità in lettera: - |
15.02 bill.EUR |
- |
- |
Descrizione business
Laboratory Corporation of America® Holdings, an S& P 500 company, is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people's health by delivering the combination of world-class diagnostics, drug development and knowledge services.
Consiglio di amministrazione & Consiglio di sorveglianza
CEO |
Adam Schechter |
Consiglio di amministrazione |
Glenn Eisenberg, Amy Summy, Anita Graham, Brian Caveney, Jon DiVincenzo, Lance Berberian, Mark Schroeder , Megan Bailey, Sandra van der Vaart, J.D., Peter J. Wilkinson |
Consiglio di sorveglianza |
Adam H. Schechter, Kerrii B. Anderson, Jean-Luc Bélingard, Jeffrey A. Davis, D. Gary Gilliland M.D., Ph.D., Kirsten Kliphouse, Garheng Kong M.D., Ph.D., Peter M. Neupert, Richelle P. Parham, Paul B. Rothman, M. D., Kathryn E. Wengel, R. Sanders Williams, M.D. |
Dati aziendali
Name: |
Laboratory Corporation of America Holdings |
Indirizzo: |
531 South Spring Street,Burlington, North Carolina 27215, USA |
Telefono: |
+1-336-229-1127 |
Fax: |
+1-336-436-1569 |
E-mail: |
-
|
Internet: |
https://www.labcorp.com/ |
Industria: |
Healthcare |
Settore: |
Medical Products |
Sub settore: |
Advanced Medical Devices |
Fine dell'anno finanziario: |
31/12 |
Flottante libero: |
78.40% |
Data dell'IPO: |
- |
Rapporti con gli investitori
Name: |
Chas Cook |
IR telefono: |
+1-336-436-5076 |
IR Fax: |
336-436-1569 |
IR e-mail: |
investor@labcorp.com
|
Company calendar
CW 24 | 12/06/2024
Dividend Payment
|